Updated March 18, 2020

InMed Pharmaceuticals

InMed Pharmaceuticals ("InMed") was founded in 2014 and is based in Vancouver, British Columbia. The company has three primary areas of focus: 1) developing cannabinoid-based pharmaceuticals, 2) manufacturing cannabinoids through biosynthesis, 3) discovering treatments through bioinformatics.

Latest Trading

$7.43
5.69%
(+0.40)
Open 7.07
Previous Close 7.03
Today's Range
7.07 7.58
52 Week Range
5.61 14.85
Volume 8.50K
Equity Market Value $1.65B
Dividend Yield 0.00
Loading Chart...

Latest Trading

$5.49
6.92%
(+0.36)
Open 5.30
Previous Close 5.13
Today's Range
5.21 5.60
52 Week Range
3.58 11.09
Volume 9.39K
Equity Market Value $1.22B
Dividend Yield 0.00
Loading Chart...